Aligos Therapeutics, Inc. (ALGS) Net Margin
- 2026-03-31: Net Margin -814.13%.
- 2025-12-31: Net Margin -11763.91%.
- 2025-09-30: Net Margin -4256.01%.
- 2025-06-30: Net Margin -1643.83%.
Complete source-backed net margin history.
- Available history
- 2023-03-31 to 2026-03-31
- Data captured
Historical Net Margin
| Date | Net Margin |
|---|---|
| 2026-03-31 | -814.13% |
| 2025-12-31 | -11763.91% |
| 2025-09-30 | -4256.01% |
| 2025-06-30 | -1643.83% |
| 2025-03-31 | 13854.66% |
| 2024-12-31 | -13556.11% |
| 2024-09-30 | -1540.72% |
| 2024-06-30 | 477.00% |
| 2024-03-31 | -5023.49% |
| 2023-12-31 | -4150.60% |
| 2023-09-30 | -1662.76% |
| 2023-06-30 | -437.61% |
| 2023-03-31 | -16396.43% |
Annual Net Margin
| Date | Net Margin |
|---|---|
| 2025-12-31 | -1106.72% |
| 2024-12-31 | -3633.65% |
| 2023-12-31 | -1416.23% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |